EP0884953B1 - Extrakt aus grünem tee, das einer kationenaustauschbehandlung und nanofiltration zur verbesserung der klarheit und farbe unterworfen wird - Google Patents

Extrakt aus grünem tee, das einer kationenaustauschbehandlung und nanofiltration zur verbesserung der klarheit und farbe unterworfen wird Download PDF

Info

Publication number
EP0884953B1
EP0884953B1 EP97907832A EP97907832A EP0884953B1 EP 0884953 B1 EP0884953 B1 EP 0884953B1 EP 97907832 A EP97907832 A EP 97907832A EP 97907832 A EP97907832 A EP 97907832A EP 0884953 B1 EP0884953 B1 EP 0884953B1
Authority
EP
European Patent Office
Prior art keywords
extract
ppm
green tea
acid
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP97907832A
Other languages
English (en)
French (fr)
Other versions
EP0884953A1 (de
Inventor
Athula Ekanayake
John Robert Bunger
Marvin Joseph Mohlenkamp Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP0884953A1 publication Critical patent/EP0884953A1/de
Application granted granted Critical
Publication of EP0884953B1 publication Critical patent/EP0884953B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/027—Nanofiltration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/20—Removing unwanted substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/20—Removing unwanted substances
    • A23F3/205—Using flocculating or adsorbing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/56—Flavouring or bittering agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2325/00—Details relating to properties of membranes
    • B01D2325/20—Specific permeability or cut-off range

Definitions

  • This application relates to a process for preparing green tea extracts having improved clarity and color.
  • This application particularly relates to a process for preparing these green tea extracts involving treatment with a cation exchange material, followed by nanofiltration.
  • This application further relates to beverages prepared with these green tea extracts.
  • tea material is well known in the art.
  • green tea is typically extracted with hot or cold water to form a dilute extract containing soluble tea solids.
  • This green tea extract can be concentrated to form a concentrated extract which is sold in frozen, refrigerated or dried form.
  • This green tea extract can also be combined with other beverage ingredients such as fruit juice, nectar, etc., to provide beverages having at least some of the desired flavor and sensory characteristics of green tea.
  • Green tea extracts initially contain high levels of unoxidized flavanols, especially monomeric catechins such as epicatechin, epigallocatechin, epigallocatechingallate and epicatechingallate that impart a desired taste quality (astringency) to the tea beverage.
  • catechin components molecular weight of from about 200 to about 500
  • these catechin components can be oxidized to higher molecular weight polyphenols, especially the theaflavins and thearubigins, in the presence of other components in the extract.
  • These other components include metal ions (especially calcium, magnesium, manganese, aluminum, zinc and iron), certain partially oxidized organic intermediates (especially quinones) that are formed when the green tea is initially extracted, and dissolved oxygen.
  • metal ions in the extract act as a catalyst, and along with the quinones and dissolved oxygen, convert the catechins to oxidized polyphenols that impart a less desirable, lingering astringency to green tea beverages.
  • oxidized polyphenols that are formed by the oxidation of the catechins can interact and react with other materials in the green tea extract, such as caffeine, protein, pectins and/or metal ions, to form even larger and heavier complexes that eventually precipitate out. As a result, the tea beverage turns from the desired pale green color to an unappealing brown color over time.
  • the tea beverage becomes cloudy, turbid and develops a visible precipitate within a few days.
  • WO95/18540 discloses a process for the production of tea extracts comprising the steps of : (a) extracting green or partially fermented tea with water at a temperature of from 20 to 65 degrees Celsius, (b) mixing the extract containing solution with protein, ( c) acidifying the protein containing extract with edible acid and a buffering salt, and (d) separating the precipitates formed.
  • US-3 481 744 also discloses a process for the production of tea extracts, which comprises a step of treating soluble tea solids with a tea extract which is at least partially decationized by ion exchange treatment and a calcium salt which does not leave a residual anion in the final extract, said extract being acidic by reason of said decationisation, the duration of said treatment, the amount of said decationised extract and the amount of said salt being sufficient tc provide a treated extract which remains clear upon reconstitution with hard water and does not form a scum.
  • the present invention relates to a process for producing a green tea extrac having improved clarity and color over time.
  • This process comprises the steps of: providing a green tea extract that has been optionally, bu preferably, obtained by:
  • the present invention further relates to the filtered green tea extract obtained by this process.
  • This filtered extract comprises, on a 1% soluble solids basis:
  • the treatment of the green tea extract with the cation exchange material improves clarity by removing metal ions, especially calcium and magnesium ions, that can bind with pectin or proteins (or pectin-like or protein-like components) in the extract to form compiexed molecules that can precipitate out and cause turbidity.
  • this treatment with the cation exchange material gets rid of these metal ions as potential catalysts of the oxidation of catechins to oxidized polyphenols such as the theaflavins and thearubigins.
  • the cation exchange material is a strongly acidic cation exchange resin
  • hydrogen ions are added that minimize or reduce the need for additional acidity (e.g., adding edible acids) extract so that beverages prepared from this extract have a smooth, less tart, astringent taste.
  • the step of contacting the treated green tea extract with a nanofiltration membrane removes the larger, high molecular weight components. These include the pectins, proteins, chlorophylls (and respective degradation products of chlorophylls), thearubigins and some theaflavins, and oxidation products due to residual metal ions/complexes.
  • the removal of these higher molecular weight components improves the clarity and color of the resultant filtered extract (the permeate), even over time.
  • the filtered extract is enriched in the desired catechins that impart desired flavor characteristics to green tea extracts.
  • An additional benefit is that the filtered extract is enriched in theanine, a desirable green tea component that mellows the astringency imparted by the catechins.
  • the treated, filtered green tea extract resulting from the process of the present invention can be used as is to provide desirable green tea beverages.
  • This green tea extract can also be combined with other beverage ingredients, including fruit juices, to provide a wide range of green tea-containing beverages.
  • Another surprising benefit of these green tea extracts in diet beverages is that the characteristic aftertaste of aspartame is substantially suppressed.
  • soluble solids refers to the soluble tea solids extracted from tea that are soluble in water, plus any other water-soluble components that are included during extraction or subsequent processing. These solids can include caffeine, flavanols, amino acids (especially theanine), edible acids (e.g., citric acid, erythrobic acid and ascorbic that added during acidic extraction as described hereafter), and their salts, proteins, sugars and related materials. All amounts given for the components (e.g., catechins) present in the tea extract or tea solids are based on 1% soluble solids.
  • green tea materials refers to green tea materials or solids obtained from the genus Camellia including C. sinensis and C. assaimica , or their hybrids, for instance, freshly gathered green tea leaves, fresh green tea leaves that are dried immediately after gathering, fresh green tea leaves that have been heat treated before drying to inactivate any enzymes present, unfermented tea, instant green tea, and aqueous extracts of these leaves.
  • Green tea materials are tea leaves, their extracts, tea plant stems and other plant materials which are related and which have not undergone partial or substantial fermentation to create oolong or black teas.
  • Other members of the genus Phyllanthus , Catechu gambir or Uncaria family of tea plants can also be used. Mixtures of unfermented teas can be also used in preparing green tea extracts according to the present invention.
  • catechins refers generally to catechins, epicatechins, and their derivatives. These derivatives include the sugar salts, sugar esters, and other edible physiologically available derivatives. Catechins, epicatechins, and their derivatives are the key flavanols present in green teas. For the purposes of the present invention, the level of catechins in the green tea solids, extracts or materials is based of the level of four of these flavanols: epicatechin, epigallocatechin, epicatechingallate, and epigallocatechin gallate. However, it should be understood that other catechins can be present in green tea, such as gallocatechin and gallocatechin gallate.
  • the term “comprising” means various components and processing steps can be conjointly employed in the green tea extracts, products and process of the present invention. Accordingly, the term “comprising” encompasses the more restrictive terms “consisting essentially of” and “consisting of.”
  • Green tea extracts useful in the present invention can be obtained from green tea materials or other natural sources of green tea.
  • the green tea extract is typically obtained by contacting green tea leaves or other green tea materials with water to provide an aqueous extract.
  • the green tea extract obtained can be processed according to the present invention without acidic extraction, i.e., extraction with an acidic aqueous solution.
  • the starting green tea extract be obtained by acidic extraction to remove some of the metal ions, such as iron, and some of the oxidized phenolic components such as theaflavins, thearubigins, and quinones.
  • Acidic extraction is preferably carried out according to the process described in U.S. Patent 5,427.806 (Ekanayake et al), June 26, 1995.
  • the green tea materials are contacted or extracted with an aqueous solution containing citric acid, as well as erythorbic acid, ascorbic acid, or a mixture of erythorbic and ascorbic acids.
  • the extraction water to which these acids are added is deionized.
  • the extraction with this acid solution can be carried out batchwise, semi-continuously, continuously or by equivalent procedures.
  • the preferred methods are batchwise or semi-continuous.
  • the green tea materials are preferably extracted at a temperature of from 40° to 50°C, most preferably from 45° to 50°C, with an aqueous solution containing 1/2 to 3/4 of the total amount of erythorbic acid/ascorbic acid and the total amount of citric acid used in the extraction process.
  • the ratio of tea material to aqueous solution is typically from 1:7 to 1:20, more preferably from 1:7 to 1:9, and most preferably 1:8.
  • the ratio of erythorbic acid/ascorbic acid to tea material used is typically from 1:6 to 1:60, preferably from 1:7 to 1:50.
  • the ratio of citric acid to tea material is typically from 1:10 to 1:40, and preferably from 1:20 to 1:35.
  • the extraction with this acid solution is carried out for a period of time sufficient to produce an aqueous extract containing typically from 0.75 to 2.5% soluble solids, preferably from 1 to 2% soluble solids.
  • This aqueous extract is separated from the residual tea materials and other solid tea residue, for example, by settling and decanting, filtration, or centrifugation.
  • a second acid solution containing the remaining erythorbic/ascorbic acid is then added to the residual tea material/residue at a ratio of typically from 1:7 to 1:20, and preferably from 1:8 to 1:15.
  • This second extraction is carried out at temperature of typically from 40° to 48°C, and preferably from 43° to 46°C.
  • the second extraction is carried out for a period of time sufficient to produce a second aqueous extract containing typically from 0.5 to 2.0% soluble solids, preferably from 1.0 to 1.5% soluble solids.
  • the first and second aqueous extracts are then combined together to provide the green tea extract for subsequent processing according to the present invention.
  • the green tea materials are again extracted with an acid solution containing citric acid and erythorbic acid, ascorbic acid or mixtures of erythorbic acid and ascorbic acid.
  • the first step of this semi-continuous method involves adding from 1/2 to 3/4 of the total amount of erythorbic acid, ascorbic acid or mixtures thereof to be used in the process and the total amount of citric acid to a tank containing water. Since the amount of acids to be added are based on the weight of tea material, the weight of tea material to be added is determined in advance.
  • the ratio of erythorbic and/or ascorbic acid to tea leaves is typically from 1:6 to 1:60, preferably from 1:7 to 1:50; and the ratio of citric acid to tea material is typically from 1:10 to 1:40, preferably about 1:35.
  • the tea materials are then added to the aqueous solution containing the acids.
  • the ratio of aqueous acid solution to tea material is typically from 1:7 to 1:20.
  • the tea materials are completely wetted.
  • the extraction is carried out at a temperature of typically from 40 to 50°C, preferably from 45° to 50°C, until the green tea solution reaches a Brix of greater than about 4.
  • From 60 to 80%, preferably from 65 to 75%, most preferably 70%, of the solution (first portion) is pumped into a filter tank.
  • This first portion of green tea extract is pumped under vacuum to limit the oxygen content of the extract to a vacuum tank to provide the green tea extract for subsequent processing according to the present invention.
  • Additional water containing the remaining erythorbic /ascorbic acids is used to flush the filter tank.
  • This flush solution is added to the filter tank until the tea extract reaches a Brix of from 1 to 3, preferably from 1.5 to 2.
  • the remainder of the green tea solution (second portion) is used to extract another quantity of fresh green tea materials, thereby increasing the soluble solids level.
  • the green tea extracts resulting from this acid extraction typically comprise from 20 to 60% soluble solids, from 3 to 17% (preferably from 2 to 15% and more preferably from 3 to 11%) erythorbic and/or ascorbic acid; from 1 to 6% (preferably from 2 to 5%, and most preferably from 2.5 to 3.3%) citric acid; from 1 to 25% (preferably from 6 to 20%, and most preferably from 7 to 15%) catechins (i.e., the combined level of epicatechins, epigallocatechins, epigallocatechingallates and epicatechingallates); and from 0.85 to 4% caffeine.
  • the theanine to caffeine ratio is typically from 1:3 to 1:100, preferably from 1:4 to 1:80.
  • the ratio of theanine to oxidized catechins e.g., theaflavins and thearubigins
  • a key aspect of the present invention is to treat the green tea extract (with or without acidic extraction) with a food grade cation exchange material.
  • This treatment with a cation exchange material removes metal ions that are the catalysts for oxidation reactions that convert the monomeric catechins to polymeric oxidized polyphenols such as the theaflavins and thearubigins. Removal of these metal ions, especially the calcium and magnesium ions, can also improve clarity by preventing the metal ions from complexing with other'components in the extract, especially the pectin or pectin-like components. It is these complexed molecules that can cause undesired turbidity.
  • This treatment is typically carried out by contacting the green tea extract with a food grade cation exchange resin.
  • the ratio of resin to extract is such that the resin is effective at removing the metal ions in the extract, especially calcium, magnesium, manganese, aluminum, zinc and iron.
  • the ratio of extract to resin is in the range of from 1:1 to 30:1, preferably from 1:1 to 15:1.
  • This ratio of extract to resin can also be important in determining whether substantial amounts of caffeine that is in the extract are removed. If there is a huge excess of cation exchange resin (e.g., ratio of extract to resin smaller than about 1:15), substantial levels of caffeine can be removed from the extract. For decaffeinated green tea extracts according to the present invention, using such an excess of cation exchange resin can be desirable.
  • the cation exchange resin can be replaced by a cation exchange membrane, i.e., where the cation exchange material is attached to a support member or substrate.
  • the green tea extract can be treated with the cation exchange resin using any conventional method that results in the intimate contact of the resin and the extract. Suitable methods include fluidized beds, stirred tanks, batch tanks, and concurrent and countercurrent flow columns. This treatment step can occur batchwise, semi-batchwise, semi-continuously or continuously.
  • the green tea extract is passed continuously through a laterally confined column of the cation exchange resin. When passed through a column or fluidized bed of the resin, the flow of the extract can be either in an upflow or downflow direction.
  • a variety of food grade cation exchange resins can be used in treating the green tea extract.
  • Particularly preferred cation exchange resins for use in the present invention are those referred to as "strongly acidic cation exchange resins" that include sulfonated copolymers of styrene and divinylbenzene, sulfite-modified cross-linked phenol-formaldehyde resins that have sulfonic acid groups in the side chains and sulfonated tetrapolymers of styrene, divinylbenzene, and acrylonitrile or methyl acrylate.
  • strongly acidic cation ion exchange resins add hydrogen ions to the extract, and thus reduce the need to add additional acids to the extract, especially when formulating beverages.
  • Suitable strongly acidic cation ion exchange resins include those sold under the tradename Amberlite IR-116, IR-118, IR-120B, XT-1022E, XT-471F (all manufactured by Organo division of Rohm & Haas), Diaion SK-1B, SK-102, SK-104, SK-106, SK-110, SK-112, SK-116, FR-01 (all manufactured by Mitsubishi Chemicals), and XFS-43281.00, XFS-43280.00, XFS-43279.00, XFS-43278.00, HCR-W2 (all manufactured by Dow Chemicals), and Wofatite-KPS (manufactured by Bayer).
  • the amount of time the green tea extract is kept in contact with the cation exchange resin is largely dependent upon the type of resin used, the degree of metal ion removal desired, the level of metal ions initially present in the extract, the amount of resin used, the temperature of the extract, and the pH of the extract.
  • the primary factor determining residence time is the degree of metal ion removal desired.
  • the extract is typically contacted with the cation exchange resin until the level of metal ions (i.e., calcium, magnesium, manganese, aluminum, zinc and iron ions) in the extract is each about 10 ppm or less.
  • the level of each of these metal ions is about 5 ppm or less.
  • the residence time of the extract in a column of the cation exchange resin is usually controlled by the flow rate of the extract through the column.
  • the extract flows through the column of resin at a rate of from 1 to 5. gal./min./ft 3 (2,22.10 -3 to 11,14.10 -3 m 3 /(s.m 3 )).
  • the extract flows through the column of resin at a rate of from 2 to 4 gal./min./ft 3 (4,45.10 -3 to 8.91.10 -3 m 3 /(s.m 3 ))
  • cation exchange treatment is carried out a temperature in the range of from 77° to 140°F (from 25° to 60°C).
  • the pH of the effluent extract initially drops.
  • the cation exchange resin becomes exhausted (i.e. loaded with ions).
  • this is usually evidenced by a sharp increase in the pH of the effluent extract above about 3.
  • Restoration is achieved by desorbing the metal ions from the cation exchange resin. Desorption of the resin is typically carried out by first washing out the resin bed with deionized water to ensure that no residual tea extract remains.
  • a strong acid such as hydrochloric acid (4 to 10 % solution) or sulfuric acid (1 to 8% solution) is fed through the resin bed, typically at a rate of from 0.15 to 0.5 gal./min./ft 3 (3.34.10 -4 to 1.11.10 -3 m 3 /(s.m 3 )) until the effluent pH is about 1, followed by washing with deionized water (typically about 6 bed volumes) until the wash water has a neutral pH.
  • deionized water typically about 6 bed volumes
  • Nanofiltration removes the higher molecular weight materials such as the pectins, proteins, chlorophylls (and respective degradation products), thearubigins. some theaflavins, and other oxidation products that form complexes with any residual metal ions in the extract.
  • nanofiltration refers to processes that use filtration membranes having a smaller molecular weight or pore size than those typically used in ultrafiltration processes, but larger than those typically used in reverse osmosis processes. Like ultrafiltration, nanofiltration rejects only a portion of the solute components above a certain molecular size while passing those of a smaller size. By contrast, reverse osmosis membranes generally reject all solute components, including ions and will pass only water molecules.
  • this nanofiltration step be carried out while the extract is at a temperature of from 100° to 140°F (from 37.8° to 60°C), preferably from 105° to 115°F (from 40.6° to 46.1°C). This is typically achieved by warming the extract after treatment with the cation exchange material and just prior to nanofiltration. Carrying out this nanofiltration step while the extract is within this temperature range is important in two respects. If the temperature is much below 100°F (37.8°C), desired amino acids such as theanine can be complexed with oxidized polyphenols to form larger molecules that are then removed by the membrane during nanofiltration of the extract. Conversely, if the temperature of the extract is much above 140°F (60°C), some of the complexed oxidized materials in the extract will disassociate to smaller molecules that can then pass through the membrane during nanofiltration.
  • the pressure at which nanofiltration is carried out can be important in the process of the present invention.
  • the pressure at which nanofiltration is carried out has to be high enough to provide adequate flow of the extract (i.e., permeate) through the membrane to achieve desired processing efficiencies.
  • the pressure should not be so high that substantial amounts of water are removed from extract, i.e. excessive concentration of the concentrate (i.e., retentate) should be avoided.
  • nanofiltration according to the present invention is carried out under a hydrostatic pressure of from 100 to 300 psi (689 to 2067 kPa), preferably from 175 to 250 psi (1205 to 1722 kPa), applied to the upstream side of the membrane.
  • Suitable nanofiltration membranes for use in the process of the present invention are made from polymers having a nominal molecular weight cut off of from 700 to 5000 Daltons (corresponding to pore sizes in the range of from 17 to 40 Angstroms).
  • Preferred nanofiltration membranes are made from polymers having a nominal molecular weight cut off of from 800 to 2000 Daltons (corresponding to pore sizes in the range of from 18 to 27 Angstroms).
  • the desired tea components e.g., catechins
  • the desired tea components e.g., catechins
  • the undesired molecules e.g., oxidized polyphenols such as some of the theaflavins and thearubigins
  • the type of polymers used in making the nanofiltration membrane can also important in the process of the present invention. Suitable polymers will be those that have less affinity for the desired components in the extract (e.g., the catechins). Polymers such as cellulose acetates, polysulfones, polyvinylidenefluorides, and the like are usually suitable for making these nanofiltration membranes. See, for example, U.S. Patent 4,604,204 (Linder et al), issued August 5, 1986, that discloses suitable cellulose acetate membrane materials. However, polyamide (e.g., nylon) type polymers are usually unsuitable as membrane materials because the polymer from which the membrane is made has too great an affinity for the catechins and will thus remove or filter out too much of these desired components from the green tea extract.
  • polyamide e.g., nylon
  • the nanofiltration membrane can be in a number of different configurations and are usually positioned within a cartridge type assembly or module.
  • Preferred membrane configurations for use in the process of the present invention are commonly referred to as "spiral wound membranes.”
  • Spiral wound membranes typically include a centrally positioned permeate or filtrate tube and at least one sheet of a membrane with appropriate spacer and backing that is spirally wound around the permeate or filtrate tube. See, for example, U.S. Patent 5,470,468 (Colby), issued November 28, 1995; U.S. Patent 5,192,437 (Chang et al), issued March 9, 1993; U.S. Patent 4,994,184 (Thalmann et al), issued February 19, 1991; U.S.
  • Patent 4,998,445 (Falk), issued January 29, 1991: U.S. Patent 4,781.830 (Olsen), issued November 1, 1988; U.S. Patent 4,301,013 (Setti et al), issued November 17, 1981, that disclose representative spiral wound membrane cartridges of the general type that can be used in carrying out nanofiltration according to the present invention.
  • the membrane In the case of spiral wound configurations, the membrane should not be so tightly wound as to unduly impede the flow rate of extract around and through the membrane.
  • tubular arrays of hollow fiber membranes where a plurality of hollow membrane fibers (e.g., 3 to 20) are disposed within a modular housing.
  • a plurality of hollow membrane fibers e.g., 3 to 20
  • U.S. Patent 4,997,564 Herczeg
  • U.S. Patent 4,992,177 (Fulk), issued February 12, 1991
  • U.S. Patent 4,959,149 (Raneri et al), issued September 25, 1990
  • U.S. Patent 4,435,289 (Breslau), issued March 6, 1984, that disclose modules containing tubular arrays of hollow fiber membranes of the general type that can be used in carrying out nanofiltration according to the present invention.
  • Flat sheet filter cartridges containing a series of 2 or more spaced apart membrane plates or sheets can also be used in carrying out nanofiltration according to the present invention.
  • the extract After the extract has been subjected to nanofiltration according to the present invention, it is desirable to cool the resulting tea extract permeate. As noted previously, the extract is typically warmed prior to nanofiltration. However, leaving the resulting extract permeate in this warm condition can cause undesired oxidation of the desired and enriched components (especially catechins) still present in the extract permeate. Typically, the extract permeate is cooled to a temperature of 60°F (15.6°C)or less, preferably 45°F (7.2°C) or less, to avoid such oxidation.
  • the nanofiltration membrane Over time, the nanofiltration membrane will become clogged with ever increasing amounts of the higher molecular weight components that are removed as the retentate. This is typically evidenced by a reduction in the flow rate of the extract permeate. Also, as the membrane becomes clogged, its processing efficiency decreases. Accordingly, the nanofiltration membrane should be periodically cleaned or replaced to maintain process efficiency and to ensure that undesired higher molecular weight components in the extract are removed to an adequate degree.
  • the treated, filtered green tea extract of the present invention can be dried to provide reconstitutable tea extract solids.
  • Conventional drying methods such as freeze drying, vacuum belt drying and spray drying can be used to provide a substantially water-free, shelf stable powder which can be reconstituted.
  • the extract is concentrated by evaporation (thermal) under a vacuum.
  • a concentrated extract suitable for drying typically has from 25 to 60% soluble solids, preferably from 30 to 60% and most preferably from 40 to 60% soluble solids. It is preferable during these concentration and drying steps that the temperature of the extract not exceed 70°C, and most preferably not exceed 50°C.
  • the treated and filtered green tea extract obtained according to the process of the present invention has a number of unique characteristics.
  • these extracts contain an enriched level of the desired catechins.
  • the enriched level of catechins present in this green tea extract is measured according to the present invention by the level of four key catechins or their derivatives: epicatechin, epigallocatechin, epicatechingallate, and epigallocatechin gallate.
  • Green tea extracts obtained according to the process of the present invention have, on a 1% soluble solids basis:
  • the green tea extracts of the present invention are also enriched in theanine (5-N-ethylglutamine), a component found primarily in tea that modifies and mellows the astringency of the catechins.
  • Green tea extracts obtained according to the process of the present invention have at least 50 ppm, preferably at least 100 ppm, most preferably at least 150 ppm, theanine.
  • Green tea extracts of the present invention that are not decaffeinated are also preferably characterized by certain minimum levels of caffeine.
  • Green tea extracts obtained according to the process of the present invention typically have at least 450 ppm, preferably at least 600 ppm, most preferably at least 700 ppm, caffeine.
  • the green tea extracts of the present invention are also characterized by certain maximum levels of metal ions.
  • the level of calcium, magnesium, manganese, aluminum, zinc and iron components is used in the present invention as an indicator of how effectively the metal ions are removed from the green tea extract during the cation exchange treatment step.
  • Green tea extracts according to the present invention have 10 ppm or less, preferably 5 ppm or less, each of calcium, magnesium, manganese, aluminum, zinc and iron components.
  • the green tea extracts of the present invention that are also preferably characterized by certain minimum levels of titratable acidity (TA).
  • TA titratable acidity
  • Green tea extracts of the present invention preferably have a TA of at least 0.1%, most preferably at least 0.2%.
  • the green tea extracts of the present invention are also characterized by improved clarity.
  • the clarity of the extract is determined according to the present invention by measuring the absorbance of the extract at 600 nm.
  • Green tea extracts obtained according to the process of the present invention have an absorbance of 0.06 or less, preferably 0.04 or less, when measured at 600 nm.
  • the green tea extracts of the present invention are also preferably characterized by improved color.
  • the color of the extract is determined according to the present invention by measuring the absorbance of the extract at 430 nm. Absorbance values measured at 430 nm reflect the degree of brownish color in the extract that can be caused by the presence of thearubigins, theaflavin monogallate, theaflavin digallate, pectins, proteins, chlorophylls and their respective degradation products.
  • Green tea extracts obtained according to the process of the present invention have an absorbance of 0.6 or less, preferably 0.4 or less, when measured at 430 nm, i.e.. have less of a brownish color.
  • the green tea extracts prepared according to the process of the present invention can be used in a variety of beverages.
  • the green tea extract or the respective green tea solids derived from the extract are included in the beverage in a flavorful amount. What constitutes a "flavorful amount" will depend on a variety of factors, including the flavor effects desired, the type of beverage involved and like factors.
  • the beverages typically comprise from 0.01 to 1.2%, preferably from 0.05 to 0.8%, green tea solids (including any other soluble solids present as a result of processing of the extract such as erythrobic, ascorbic and/or citric acid during acidic extraction).
  • the beverages can comprise an effective amount of other flavor systems such as a fruit juice, vegetable juice, fruit flavors, vegetable flavor, as well as mixtures of these flavor components.
  • the combination of green tea together with fruit juices can have an appealing taste.
  • the juice can be derived from apple, cranberry, pear, peach, plum, apricot, nectarine, grape, cherry, currant, raspberry, gooseberry, elderberry, blackberry, blueberry, strawberry, lemon, lime, mandarin, orange, grapefruit, cupuacu, potato, tomato, lettuce, celery, spinach, cabbage, watercress, dandelion, rhubarb, carrot, beet, cucumber, pineapple, coconut, pomegranate, kiwi, mango, papaya, banana, watermelon, tangerine and cantaloupe.
  • Preferred juices are derived from apple, pear, lemon, lime, mandarin, grapefruit, cranberry, orange, strawberry, tangerine, grape, kiwi, pineapple, passion fruit, mango, guava, raspberry and cherry.
  • Citrus juices, preferably grapefruit, orange, lemon, lime, and mandarin juices, as well as juices derived from mango, apple, passion fruit and guava, as well as mixtures of these juices are most preferred.
  • the amount of these other flavor systems that is effective depends upon a number of factors, including the source(s) of the flavor system, the flavor effects desired and like factors.
  • the beverages can comprise from 0.1 to 90%, preferably from 3 to 35%, and more preferably from 3 to 10% juice.
  • the weight percentage of fruit juice is based on a single strength 2° to 16° Brix fruit juice.
  • the fruit and/or vegetable juice can be incorporated into the beverage as a puree, comminute or as a single strength or concentrated juice.
  • the incorporation of the fruit juice as a concentrate with a solids content (primarily as sugar solids) of from 20 ° to 80° Brix.
  • the flavoring system according to the present invention can also comprise natural and/or artificial flavors, flavor oils, extracts, oleoresins, essential oils and the like, known in the art for use as flavorants in beverages.
  • These flavors can be selected from fruit flavors, botanical flavors, vegetable flavors and mixtures thereof.
  • Particularly preferred fruit flavors are the citrus flavors including orange flavors, lemon flavors, lime flavors and grapefruit flavors.
  • a variety of other fruit flavors can be used such as apple flavors, grape flavors, cherry flavors, pineapple flavors, elderberry flavors, cupuacu flavors and the like.
  • Particularly preferred botanical flavors are hibiscus, marigold, rose hips, orange blossom, cammomile, elderberry blossom, malve, lemon grass and chrysanthemum.
  • the flavor(s) are typically incorporated into the beverage as a flavor emulsions.
  • the flavor emulsion typically comprises a blend of various flavors and can be employed in the form of an emulsion, alcoholic extract, or can be spray dried.
  • the flavor emulsion can also include clouding agents, with or without weighting agents, as described in U.S. Patent 4,705,691 (Kupper, et al), issued November 10, 1987.
  • the beverages typically comprise from 0.2 to 5%, preferably from 0.5 to 3%, most preferably from 0.8 to 2%, of the emulsion.
  • Flavor emulsions are typically prepared by mixing flavoring oils (0.001 to 20%) with an emulsifying agent (1 to 30%) and water, along with clouding agents if an opaque beverage is desired. Flavor emulsions processed to provide emulsion droplet particles with diameters of from 0.1 to 3.0 microns are suitable.
  • the emulsion droplet particles are 2.0 microns or less in diameter. Most preferably, the emulsion droplet particles are 1.0 microns or less in diameter.
  • the emulsifying agent coats the particularized flavor oil to aid in preventing coalescence and in maintaining an appropriate dispersion.
  • Weighting agents (which can also act as clouding agents) can be used to keep the emulsion droplets dispersed in the beverage. Examples of such weighting agents are brominated vegetable oils (BVO) and resin esters, in particular the ester gums. See L.F. Green, DEVELOPMENTS IN SOFT DRINKS TECHNOLOGY, Vol. 1 (Applied Science Publishers Ltd. 1978) pages. 87-93, for a further description of the use of weighting and clouding agents in liquid beverages.
  • the beverages can, and typically will, contain an effective amount of one or more sweeteners, including carbohydrate sweeteners and natural and/or artificial no/low calorie sweeteners.
  • the amount of the sweetener used i.e., "effective amount" in the beverages of the present invention typically depends upon the particular sweetener used and the sweetness intensity desired. For no/low calorie sweeteners, this amount varies depending upon the sweetness intensity of the particular sweetener.
  • the beverages can be sweetened with any of the carbohydrate sweeteners, preferably mono- and or di-saccharide sugars.
  • Sugar sweetened beverages will typically comprise from 0.1 to 20%, most preferably from 6 to 14%, sugar.
  • These sugars can be incorporated into the beverages in solid or liquid form but are typically, and preferably, incorporated as a syrup, most preferably as a concentrated syrup such as high fructose corn syrup.
  • these sugar sweeteners can be provided to some extent by other components of the beverage such as the fruit juice component, flavorants, and so forth.
  • Preferred sugar sweeteners for use in these beverages are sucrose, fructose, glucose, and mixtures thereof.
  • Fructose can be obtained or provided as liquid fructose, high fructose corn syrup, dry fructose or fructose syrup, but is preferably provided as high fructose corn syrup.
  • High fructose corn syrup (HFCS) is commercially available as HFCS-42, HFCS-55 and HFCS-90, which comprise 42%, 55% and 90%, respectively, by weight of the sugar solids therein as fructose.
  • Other naturally occurring sweeteners or their purified extracts such as glycyrrhizin, the protein sweetener thaumatin, the juice of Luo Han Guo disclosed in, for example, U. S. Patent 5,433,965 (Fischer et al), issued July 18, 1995, and the like can also be used in the beverages of the present invention.
  • Artificial no caloric or low calorie sweeteners that can be incorporated into the beverages alone, or in combination with carbohydrate sweeteners, include, for example, saccharin, cyclamates, acetosulfam, L-aspartyl-L-phenylanaine lower alkyl ester sweeteners (e.g., aspartame), L-aspartyl-D-alanine amides disclosed in U.S. Patent 4,411,925 (Brennan et al), L-aspartyl-D-serine amides disclosed in U.S. Patent 4,399,163 (Brennan et al), L-aspartyl-L-1-hydroxymethyl-alkaneamide sweeteners disclosed in U.S.
  • saccharin cyclamates, acetosulfam
  • L-aspartyl-L-phenylanaine lower alkyl ester sweeteners e.g., aspartame
  • Patent 4,338,346 (Brand), L-aspartyl-1-hydroxyethylalkaneamide sweeteners disclosed in U.S. Patent 4,423,029 (Rizzi), L-aspartyl-D-phenylglycine ester and amide sweeteners disclosed in European Patent Application 168,112 (Janusz), published January 15, 1986, and the like.
  • a particularly preferred low calorie sweetener is aspartame.
  • Beverages sweetened with aspartame have a characteristic aftertaste that is unattractive to many. Surprisingly, this aspartame aftertaste is substantially suppressed in beverages containing green tea extracts prepared according to the present invention.
  • This surprising benefit is especially noticeable in beverages where aspartame is the primary source of sweetness, e.g., mixtures of aspartame and a carbohydrate sweetener such as high fructose corn syrup, where the high fructose corn syrup is present at a level about half or less that typically required for imparting adequate sweetness intensity.
  • the beverages can comprise other optional beverage ingredients, including preservatives (e.g., organic acids), colorants and so forth. These beverages can also be fortified with from 0 to 110% of the U.S. Recommended Daily Allowance (RDA) of vitamins and minerals, provided that such vitamins and minerals do not substantially alter the desired properties of the beverage (e.g., ambient display times), and that such vitamins and minerals are chemically and physically compatible with the other essential components of beverage.
  • RDA Recommended Daily Allowance
  • vitamins and minerals are especially preferred.
  • vitamin A e.g., vitamin A palmitate
  • provitamins thereof e.g., ⁇ -carotene
  • vitamin Bl e.g., thiamin HCl
  • vitamin C i.e., ascorbic acid
  • Beverages typically contain from 80 to 90% water for carbohydrate sweetened beverages and up to 99% water for diet type beverages, i.e., those at least partially sweetened with low and/or noncaloric sweeteners.
  • the water is deionized.
  • Beverage concentrates formulated with carbohydrate sweeteners typically contain from 25 to 75%, preferably from 40 to 60% water.
  • the beverage water can be carbonated.
  • a beverage will be considered to be carbonated if it comprises more than 30%, preferably more than 100% by volume of the beverage of solubilized carbon dioxide.
  • Carbonated beverages comprise typically from 100 to 450%, preferably from 200 to 350%, carbon dioxide by volume of the beverage.
  • Carbonated beverages usually contain very low levels or no pulp.
  • the carbonated beverage can then be placed in a container such as a HDPE bottle or other suitable container and sealed.
  • a container such as a HDPE bottle or other suitable container and sealed.
  • the levels of the specific catechins and caffeine in the green tea extracts and green tea solids are determined according to the present invention by an HPLC based method, using UV absorbance for detection, as described by S. Kuhr and U. H. Engelhardt, "Determination of Flavanols, Theogallin, Gallic Acid and Caffeine in Tea Using HPLC," Z. Lebensm.-Schs.-Forsch., Vol. 192, (1991), pages 526-529.
  • the levels of theanine in the green tea extracts and green tea solids are determined according to the present invention by capillary electrophoresis using laser induced fluorescence detection, as described in H. E. Schwartz, K. J. Ulfelder, F-T .A. Chen and S. L. Pentoney, 1994. "The Utility of Laser-Induced Fluorescence Detection in Applications of Capillary Electrophoresis.” J . Cap. Elec. , Vol. 1, (1994) pages 36-54.
  • the levels of each of the metal ions in the green tea extracts and green tea solids are determined according to the present invention by inductively coupled plasma (ICP) emission spectrometry, as described in R. L. Dahlquist and J. W. Knoll, "Inductively Coupled Plasma-Atomic Emission Spectrometry: Analysis of Biological Materials and Soils for Major, Trace and Ultra-Trace Elements," Appl. Spectrosc. , Volume 32, No. 1, (1978), pages 1-30.
  • ICP inductively coupled plasma
  • the titratable acidity of the green tea extracts and green tea solids is determined according to the present invention by back titration with a 0.3125 N NaOH solution to a phenolphthalein endpoint, as described in S. Nagy and J. A. Attaway, CITRUS NUTRITION AND QUALITY (ACS Symmposium Series 143 1980), pages 295-98.
  • Absorbance values at 600 nm and 430 nm for the green tea extracts and green tea solids are determined according to the present invention by visible spectrophotometry using a Beckman DU-9 spectrophotometer with distilled water as the blank.
  • °Brix values for the green tea extracts and green tea solids are determined according to the present invention by using an Abbe refractometer.
  • the levels of soluble solids in the green tea extracts and green tea solids are determined according to the present invention by using a Zeiss refractometer set at 29°C and a calibration table based on dissolved solids.
  • Ascorbic acid (90.7 g.) and citric acid (136.1 g.) are dissolved in deionized water (176 kg.) at a temperature of 46°C.
  • Chinese green tea fannings (4.54 kg.) are slurried in the solution until the leaves are fully wetted.
  • the tea extract is withdrawn from the slurry using a tubular filter while at the same time warm deionized water (46°C) is pumped into the slurry at the same rate to maintain the liquid level in the slurry. Extraction is continued until the °Brix of the extract leaving the slurry reaches about 1%.
  • the combined extract has a pH of 4.2 and weighs 102 kg. and has 1.72% soluble solids.
  • the extract is then cooled to ambient temperature and is then passed through a packed column (0.22 ft 3 column bed) (0.006 m 3 ) of Dowex® HCR-W2, a strongly acidic cation exchange resin made by Dow Chemical of Midland, Michigan, at the rate of about 0.4-0.6 gallons per minute.
  • the extract treated with the resin has a pH of 2.7 and has the same % soluble solids as the starting extract.
  • This treated extract is then passed through a filtration cartridge containing an OSMO SP-12® nanofiltration membrane (made by Osmonics, Inc. of Minnetonka, Minnesota) with concentrate (retentate) recycling.
  • the cellulose acetate polymer from which the membrane is made has a nominal molecular weight cut off of 1000 Daltons (corresponding to a pore size of about 20 Angstroms).
  • the pressure across the membrane is maintained at 200 psi (1378 kPa) which results in a permeate flow rate of about 500 mL/min.
  • the feed temperature to the filtration cartridge is maintained at 42°-43°C by means of a cooling water spray on the membrane housing.
  • the resulting extract permeate is found to have: 1.12 % soluble solids; 378 ppm epicatechin, 800 ppm epigallocatechin, 1409 ppm epigallocatechingallate and 280 ppm epicatechingallate; 992 ppm caffeine; 200 ppm theanine; 0.012 absorbance units at 600 ⁇ m; 0.16 absorbance units at 430 ⁇ m; 2.5 ppm aluminum, 7.3 ppm calcium, 0.8 ppm iron, 4 ppm magnesium, 3 ppm manganese and ⁇ 1 ppm zinc; 0.25 % titratable acidity.
  • the extract permeate is then cooled to about 10°C before evaporation under vacuum to yield a tea concentrate.
  • Erythorbic acid (510 g.) and citric acid (216 g.) are dissolved in deionized water (34.5 kg.) at a temperature of 125°F (51.7°C).
  • Chinese green tea fannings (4.31 kg.) are slurried in the solution until the leaves are fully wetted.
  • the tea extract is withdrawn from the slurry using a tubular filter while at the same time warm (125°F, 51.7°C) deionized water is pumped into the slurry at the same rate to maintain the liquid level in the slurry. Extraction is continued until the °Brix of the extract leaving the slurry reaches about 1%.
  • the combined extract (185 kg.) has a pH of 3.8, and has 2.08% soluble solids.
  • the extract is then cooled to ambient temperature and is then passed through a packed column (0.98 ft 3 column bed) (0.098 m 3 ) of Wofatit KPS® , a strongly acidic cation exchange resin (sulfonated copolymer of polystyrene and divinylbenzene) made by Bayer of Pittsburgh, Pennsylvania, at the rate of about 0.4-0.6 gallons per minute (2.52.10 -2 to 3.78.10 -2 m 3 /s).
  • the extract treated with the resin has a pH of 2.5 and has the same % soluble solids as the starting extract.
  • This treated extract is then passed through a filtration cartridge containing an OSMO SP-12® nanofiltration membrane with concentrate (retentate) recycling and using the same pressure and flow rate conditions as Example I.
  • the feed temperature to the filtration cartridge is maintained at 100°-105°F (37.8°-40.6°C) by means of an on line heat exchanger.
  • the resulting extract permeate is found to have: 0.75 % soluble solids; 223 ppm epicatechin, 503 ppm epigallocatechin, 670 ppm epigallocatechingallate and 138 ppm epicatechingallate: 551 ppm caffeine; 115 ppm theanine: 0.007 absorbance units at 600 ⁇ m; 0.06 absorbance units at 430 ⁇ m; 5 ppm aluminum, 6 ppm calcium, 0.9 ppm iron, 5 ppm magnesium. 2 ppm manganese and ⁇ 1 ppm zinc; 0.17 % titratable acidity.
  • the permeate is then cooled to about 50°F (10°C) before evaporation under vacuum to yield a tea concentrate.
  • Chinese green tea fannings (817 kg.) are slurried in softened well water (2,000 gallons) containing erythorbic acid (91 kg.) and citric acid (41 kg.) at a temperature of 125°F, with stirring, until the extract °Brix reaches about 4.5 (75 minutes).
  • the slurry is pumped into a filter which separates the extract (first extract) from the used tea leaves.
  • Erythorbic acid (11.3 kg.) is dissolved in warm (125°F) (51.6°C) softened well water (2.000 gallons) (7.57 m 3 ) to provide an acid solution used to flush the residual tea leaf material retained in the filter until the resulting rinse has a °Brix of about 1.8.
  • the first extract is cooled to room temperature and is then passed through a packed column (18.5 ft 3 column bed) (0,53 m 3 ) of Dowex® HCR-W2 at the rate of about 35-40 gallons per minute (2.20 to 2.52 m 3 /s).
  • the extract treated with the resin has a pH of about 2.8.
  • This treated extract is then passed through an OSMO 80B® nanofiltration unit equipped with 40, 16 cm diameter OSMO SP-12® membranes.
  • the pressure across the membranes is maintained at 200 psi (1378 kPa) which results in a permeate flow rate of about 15 gallons per minute.
  • the feed temperature to the filtration unit is maintained at 110°-115°F (43.3°-46.1°C) by means of an in line heat exchanger.
  • This extract permeate is then cooled to about 40°F (4.4°C) before evaporation under vacuum to yield a green tea concentrate.
  • a sugar sweetened beverage is formulated from the following ingredients: Ingredient Amount (%) 50 Kg Batch (g/50 kg Beverage) Potassium sorbate 0.03 15 Potassium chloride 0.03 15 Sodium citrate 0.1 50 White Grape Juice Concentrate 1.2 600 Xanthan Gum 0.10 50 High fructose corn syrup-55 12.0 6,000 Ascorbic Acid 0.04 20 Flavor 0.2 100 Red #40 Solution(0.3%/water) 0.20 100 Green tea concentrate (50 Brix) 0.5 250 Citric acid 0.14 70 Phosphoric acid (1 Molar) 0.02 10 R.O. water 85.44 42,720 Total 100.0 50,000 g
  • a diet type beverage is formulated from the following ingredients: Ingredient Amount (%) 34.1 kg Batch (grams) Potassium sorbate 0.035 11.9 Potassium chloride 0.028 9.55 Sodium citrate 0.1 34.1 Aspartame 0.04 13.6 Flavor 0.2 68.2 Caramel color 0.075 25.6 Green tea extract (50 Brix) 0.60 205 Citric acid 0.04 13.6 Phosphoric acid solution (1 Molar) 0.21 71.6 Velcorin (dimethyl dicarbonate) 0.02 6.82 R.O. water 98.6 33,640 Carbon dioxide 3 volumes 3 volumes Total 100.0 34.100 grams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Water Supply & Treatment (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)

Claims (8)

  1. Ein Verfahren zum Bereiten eines Grüntee-Extraktes mit verbesserter Klarheit und Farbe, wobei das Verfahren die Stufen umfaßt:
    a. Behandeln des Grüntee-Extraktes mit einer Menge eines lebensmitteltauglichen Kationenaustauschers, die wirksam ist, um die in dem Extrakt vorhandenen Metallkationen zu entfernen; und
    b. Kontaktieren des behandelten Extraktes mit einer Nanofiltrationsmembran, während der behandelte Extrakt bei einer Temperatur von 100° bis 140°F (von 37,8° bis 60°C) ist, um ein Extraktpermeat zu ergeben, das auf einer 1%-Basis löslicher Feststoffe enthält:
    (1) eine Mischung aus Katechinen umfassend:
    (a) wenigstens 130 ppm Epikatechine;
    (b) wenigstens 300 ppm Epigallokatechine;
    (c) wenigstens 350 ppm Epigallokatechingallate;
    (d) wenigstens 60 ppm Epikatechingallate;
    (2) wenigstens 50 ppm Theanin;
    (3) 10 ppm oder weniger je von Kalzium-, Magnesium-, Mangan-, Aluminium-, Zink- und Eisenionen;
    (4) eine bei 600 nm gemessene Absorption von 0,06 oder weniger;
  2. Das Verfahren von Anspruch 1, wobei der Grüntee-Extrakt vor Stufe (a) erhalten wird durch:
    (1) Kontaktieren des Grünteematerials mit einer wässerigen Säurelösung, enthaltend Zitronensäure und D-Araboascorbinsäure, Ascorbinsäure, oder Mischungen von D-Araboascorbinsäure und Ascorbinsäure, in einem Verhältnis von Teematerial und Säurelösung von 1:7 bis 1:20, bei einem Verhältnis von D-Araboascorbinsäure, Ascorbinsäure, oder Mischungen derselben zum Teematerial von 1:6 bis 1:60, und bei einem Verhältnis von Zitronensäure zu Teematerial von 1:10 bis 1:40, um einen ersten, wässerigen Extrakt zu ergeben, der lösliche Grüntee-Feststoffe enthält;
    (2) Abtrennen des ersten, wässerigen Extraktes vom restlichen Grünteematerial;
    (3) Kontaktieren des restlichen Grünteematerials von Stufe (2) mit einer wässerigen Säurelösung, enthaltend D-Araboascorbinsäure, Ascorbinsäure, oder Mischungen von D-Araboascorbinsäure und Ascorbinsäure bei einem Verhältnis von Teematerial zur Säurelösung von 1:7 bis 1:20, um einen zweiten, wässerigen Extrakt, enthaltend lösliche Grüntee-Feststoffe zu ergeben;
    (4) Abtrennen des zweiten, wässerigen Extraktes vom restlichen Grünteematerial; und
    (5) Vereinigen des ersten und des zweiten wässerigen Extraktes, um den Grüntee-Extrakt zu ergeben.
  3. Das Verfahren von einem der Ansprüche 1 bis 2, wobei Stufe (a) ausgeführt wird, indem der Grüntee-Extrakt mit dem Kationenaustauscherharz bei einem Verhältnis von Extrakt zu Harz im Bereich von 1:1 bis 30:1, vorzugsweise von 1:1 bis 15:1 kontaktiert wird, vorzugsweise bis der Gehalt an Kalzium-, Magnesium-, Mangan-, Aluminim-, Zink- und Eisenionen in dem Extrakt jeweils 10 ppm oder kleiner ist, besonders bevorzugt 5 ppm oder kleiner.
  4. Das Verfahren von Anspruch 1 bis 3, wobei das Harz ein stark saueres Kationenaustauscherharz ist, -vorzugsweise ausgewählt aus der Gruppe bestehend aus sulfonierten Copolymeren von Styrol und Divinylbenzol, sulfit-modifizierten, vernetzten Phenol-Formaldehydharzen mit Sulfonsäuregruppen in den Nebenketten, und sulfonierten Tetrapolymeren von Styrol, Divinylbenzol und Acrylnitril oder Methylacrylat.
  5. Das Verfahren von einem der Ansprüche 1 bis 4, wobei Stufe (a) ausgeführt wird, indem der Extrakt durch eine Säule des Harzes bei einer Temperatur im Bereich von 77° bis 140°F (von 25° bis 60°C), vorzugsweise von 105° bis 115°F (von 40,6° bis 46,1°C) geleitet wird und wobei der Extrakt durch die Säule des Harzes mit einer Geschwindigkeit von 1 bis 5 gal./min./ft3 (2,22 . 10-3 bis 11,14 . 10-3 m3/(s.m3)), vorzugsweise von 2 bis 4 gal./min./ft.3 (4,45 . 10-3 bis 8,91 . 10-3 m3/(s.m3))strömt.
  6. Das Verfahren von einem der Ansprüche 1 bis 5, wobei Stufe (b) unter einem hydrostätischen Druck von 100 bis 300 psi (689 bis 2067 kPa), vorzugsweise von 175 bis 250 psi (1205 - 1722 kPa), ausgeführt wird.
  7. Das Verfahren von einem der Ansprüche 1 bis 6, wobei die Nanofiltrationmembran aus einem Polymer hergestellt ist, das ein nominelles Molargewicht im Bereich von 700 bis 5000 Daltons, vorzugsweise von 800 bis 2000 Daltons hat.
  8. Ein Grüntee-Extrakt, der auf einer 1%-Basis löslicher Feststoffe enthält:
    a. Eine Mischung von Katechinen enthaltend:
    (1) wenigstens 130 ppm, vorzugsweise wenigstens 200 ppm, besonders bevorzugt wenigstens 270 ppm, Epikatechine;
    (2) wenigstens 300 ppm, vorzugsweise wenigstens 450 ppm, besonders bevorzugt wenigstens 550 ppm, Epigallokatechine;
    (3) wenigstens 350 ppm, vorzugsweise wenigstens 500 ppm, besonders bevorzugt wenigstens 850 ppm, Epigallokatechingallate;
    (4) wenigstens 60 ppm, vorzugsweise wenigstens 100 ppm, besonders bevorzugt wenigstens 175 ppm, Epikatechingallate;
    b. wenigstens 50 ppm, vorzugsweise wenigstens 100 ppm, besonders bevorzugt wenigstens 150 ppm, Theanin;
    c. 10 ppm oder weniger, vorzugsweise 5 ppm oder weniger, je von Kalzium-, Magnesium-, Mangan-, Aluminium-, Zink- und Eisenionen;
    d. gegebenenfalls wenigstens 450 ppm, vorzugsweise wenigstens 600 ppm, besonders bevorzugt wenigstens 700 ppm, Koffein;
    e. gegebenenfalls einen titrierbaren Säuregrad von wenigstens 0,1%, vorzugsweise wenigstens 0,2%;
    f. eine bei 600 nm gemessene Absorption von 0,06 oder weniger, vorzugsweise 0,04 oder weniger;
    g. gegebenenfalls eine bei 430 nm gemessene Absorption von 0,6 oder weniger.
EP97907832A 1996-02-26 1997-02-21 Extrakt aus grünem tee, das einer kationenaustauschbehandlung und nanofiltration zur verbesserung der klarheit und farbe unterworfen wird Expired - Lifetime EP0884953B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US606907 1984-05-04
US08/606,907 US6063428A (en) 1996-02-26 1996-02-26 Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
PCT/US1997/002901 WO1997030597A1 (en) 1996-02-26 1997-02-21 Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color

Publications (2)

Publication Number Publication Date
EP0884953A1 EP0884953A1 (de) 1998-12-23
EP0884953B1 true EP0884953B1 (de) 2001-12-12

Family

ID=24430001

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97907832A Expired - Lifetime EP0884953B1 (de) 1996-02-26 1997-02-21 Extrakt aus grünem tee, das einer kationenaustauschbehandlung und nanofiltration zur verbesserung der klarheit und farbe unterworfen wird

Country Status (11)

Country Link
US (3) US6063428A (de)
EP (1) EP0884953B1 (de)
JP (2) JP3174065B2 (de)
CN (1) CN1079646C (de)
AT (1) ATE210384T1 (de)
AU (1) AU1972997A (de)
BR (1) BR9707675A (de)
CA (1) CA2248295C (de)
DE (1) DE69709065T2 (de)
ES (1) ES2165585T3 (de)
WO (1) WO1997030597A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058882A (zh) * 2013-02-04 2013-04-24 湖南省茶业集团股份有限公司 一种分离天然茶氨酸的方法

Families Citing this family (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1515095A (en) * 1994-12-13 1996-07-03 Wm. Wrigley Jr. Company Improved chewing gum containing salatrim
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US6063428A (en) * 1996-02-26 2000-05-16 The Procter & Gamble Company Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color
JP3152416B2 (ja) * 1996-12-12 2001-04-03 株式会社 伊藤園 茶の製造方法
US6120823A (en) * 1997-10-28 2000-09-19 Lipton, Divsion Of Conopco, Inc. Flavoring materials used in foodstuffs
US6036986A (en) * 1997-10-28 2000-03-14 Lipton, Division Of Conopco, Inc. Cinnamic acid for use in tea containing beverages
US6022576A (en) * 1997-10-28 2000-02-08 Lipton, Division Of Conopco, Inc. Flavoring materials for use in tea containing beverages
EP0919139A1 (de) * 1997-12-01 1999-06-02 The Procter & Gamble Company Eine wirksame Menge einer süssigkeitseinschränkenden Zusammensetzung enthaltendes Getränk
US6682766B2 (en) 1997-12-01 2004-01-27 The Procter & Gamble Company Beverage comprising an effective amount of flavanols as sweetness cutting composition
EP0919138A1 (de) * 1997-12-01 1999-06-02 The Procter & Gamble Company Getränk mit einer wirksamer Menge an Flavanols als süssigkeitseinschränkende Zusammensetzung
ATE354359T1 (de) * 1998-02-23 2007-03-15 Taiyo Kagaku Kk Theanin-beinhaltende zusammenstellung
DE19821920A1 (de) * 1998-05-15 1999-11-18 Sawo Ag Glarus Teekonzentrat
KR100753012B1 (ko) * 1999-08-03 2007-08-30 가부시키가이샤 야쿠루트 혼샤 발효유 음식품 및 그의 제조방법
DE60031921T2 (de) * 1999-08-16 2007-09-20 Dsm Ip Assets B.V. Verfahren zu Herstellung von Epigallocatechin Gallate
US6383392B1 (en) 1999-11-16 2002-05-07 Roche Vitamins, Inc. Process for concentrating epigallocatechin gallate
EP1103550B1 (de) * 1999-11-16 2007-01-17 DSM IP Assets B.V. Verfahren zum Konzentrieren von Catechinlösungen mittels Membranen
FI20000004A0 (fi) * 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
CA2395447A1 (en) 2000-01-28 2001-08-02 Robert Joseph Sarama Palatable arginine compounds and uses thereof for cardiovascular health
US6716462B2 (en) 2000-04-12 2004-04-06 Mid-America Commercialization Corporation Nutritionally balanced traditional snack foods
US6827954B2 (en) * 2000-04-12 2004-12-07 Mid-America Commercialization Corporation Tasty, convenient, nutritionally balanced food compositions
US6726943B2 (en) 2000-04-12 2004-04-27 Mid-America Commercialization Corporation Nutritionally balanced snack food compositions
US6846501B2 (en) 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
US6899905B2 (en) 2000-04-12 2005-05-31 Mid-America Commercialization Corporation Tasty, ready-to-eat, nutritionally balanced food compositions
US20020012733A1 (en) * 2000-04-12 2002-01-31 The Procter & Gamble Company Compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels
US6720015B2 (en) 2000-04-12 2004-04-13 Mid-America Commercialization Corporation Ready-to-eat nutritionally balanced food compositions having superior taste systems
JP4179741B2 (ja) * 2000-09-22 2008-11-12 アサヒ飲料株式会社 リンゴポリフェノールを含有する飲料
WO2002039822A2 (en) * 2000-11-17 2002-05-23 Kao Corporation Packaged beverages
MXPA03007455A (es) * 2001-02-21 2004-07-30 Basf Ag Metodo y produccion de acido d-pantotenico y las sales de este como adyuvante en productos alimenticios para animales.
JP3360073B2 (ja) * 2001-02-22 2002-12-24 花王株式会社 飲 料
US20020187219A1 (en) * 2001-03-29 2002-12-12 The Procter & Gamble Co. Low glycemic response compositions
JP3592681B2 (ja) * 2001-05-16 2004-11-24 花王株式会社 容器詰飲料
FR2829946B1 (fr) * 2001-09-26 2003-12-19 Tech Avancees & Membranes Ind Nouvelles membranes inorganiques de nanofiltration
JP3378577B1 (ja) * 2001-09-28 2003-02-17 花王株式会社 飲 料
JP3403400B1 (ja) * 2001-09-28 2003-05-06 花王株式会社 容器詰飲料
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
US6632449B2 (en) 2001-11-20 2003-10-14 The Procter & Gamble Co. Compositions and kits comprising a defined boron compound and methods of their preparation
US20050100639A1 (en) * 2002-02-11 2005-05-12 Edizone, Lc Method for a consumer to create his own tasty beverage
US20040142048A1 (en) * 2002-02-22 2004-07-22 Morre Dorothy M. Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
US20090022852A1 (en) * 2002-06-21 2009-01-22 Dnp Canada Inc. Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins
WO2004000045A2 (en) * 2002-06-21 2003-12-31 Canacure Corporation Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
US20040096547A1 (en) * 2002-11-15 2004-05-20 Mario Ferruzzi Healthy alternative ready-to-drink energy beverage
EP1576887B1 (de) 2002-12-24 2007-10-24 Kao Corporation Verpacktes teegetränk
JP3569276B2 (ja) * 2003-02-04 2004-09-22 花王株式会社 容器詰飲料及びその製造法
AU2004257595B2 (en) * 2003-07-03 2007-12-20 The Procter & Gamble Company Compositions containing green tea catechins and one or more polyvalent mineral cations
CN100579504C (zh) 2003-09-09 2010-01-13 Dsmip资产公司 包含一种或多种氧化敏感物质的具有口腔活性的基本无水的局部试剂
US7303773B2 (en) * 2003-10-21 2007-12-04 The Procter & Gamble Company Process for enriching extracts of natural theanine
JP3597857B2 (ja) * 2003-10-31 2004-12-08 花王株式会社 容器詰茶飲料
JP3597856B2 (ja) * 2003-10-31 2004-12-08 花王株式会社 容器詰茶飲料
JP4986375B2 (ja) * 2003-11-12 2012-07-25 三井農林株式会社 容器詰め茶飲料の透過率の変化抑制方法
KR101202565B1 (ko) * 2003-12-02 2012-11-19 가오 가부시키가이샤 용기포장음료
US7357956B2 (en) * 2003-12-03 2008-04-15 Unilever Bestfoods, North America, Division Of Conopco, Inc. Tea beverage with improved flavor
JP3766670B2 (ja) 2003-12-16 2006-04-12 花王株式会社 容器詰飲料
US20070141219A1 (en) * 2003-12-18 2007-06-21 Kao Corporation Bottle beverage
GB0409846D0 (en) * 2004-05-04 2004-06-09 Unilever Plc Tea extracts
US20050260302A1 (en) * 2004-05-19 2005-11-24 The Procter & Gamble Company Nutritionally balanced traditional snack foods having a low glycemic response
US7232585B2 (en) * 2004-06-24 2007-06-19 Xel Herbaceuticals, Inc. Green tea formulations and methods of preparation
WO2006012213A2 (en) * 2004-06-25 2006-02-02 Tea Guard Llc Composition and method for delivery of phytochemicals
EP1618793A1 (de) * 2004-07-20 2006-01-25 Cognis IP Management GmbH Extrakte von Camellia sinensis mit niedrigem Alkaloidgehalt
JP4702824B2 (ja) * 2004-07-22 2011-06-15 三井農林株式会社 茶ポリフェノール組成物及びその製造方法
JP4247166B2 (ja) * 2004-08-06 2009-04-02 花王株式会社 非重合体カテキン類含有茶抽出物の製造法
GB0418917D0 (en) * 2004-08-25 2004-09-29 Unilever Plc Process for making tea
US7666452B2 (en) 2006-01-25 2010-02-23 Ito En, Ltd. Beverage comprising cathechins and caffeine
GB0419691D0 (en) * 2004-09-04 2004-10-06 Unilever Plc Process for making tea
CN1748582B (zh) * 2004-09-17 2011-03-09 太阳化学株式会社 风味改善组合物、饮食品和医药品以及改善饮食品和医药品风味的方法
ATE450159T1 (de) * 2004-09-22 2009-12-15 Taiyokagaku Co Ltd In verschlossenem behältnis verpacktes getränk
DE102004045829A1 (de) * 2004-09-22 2006-04-06 Zf Friedrichshafen Ag Einlegen eines Anfahrgangs bei einem automatisierten Synchrongetriebe
GB0421827D0 (en) * 2004-10-01 2004-11-03 Unilever Plc Process for making tea extracts
GB0421832D0 (en) * 2004-10-01 2004-11-03 Unilever Plc Process for making tea extracts
GB0421830D0 (en) * 2004-10-01 2004-11-03 Unilever Plc Process for making tea extracts
JP3742094B1 (ja) * 2004-11-04 2006-02-01 花王株式会社 非茶系容器詰飲料
US20060099318A1 (en) * 2004-11-04 2006-05-11 Kao Corporation Non-tea-based, packaged beverages
JP3742096B1 (ja) * 2005-02-08 2006-02-01 花王株式会社 非茶系容器詰飲料
ZA200704521B (en) * 2004-12-08 2008-08-27 Unilever Pic Food or beverage product comprising theanine and caffeine for enhancing mental alertness
JP4354902B2 (ja) * 2004-12-24 2009-10-28 花王株式会社 緑茶抽出物の精製物及びそれを配合した高濃度カテキン含有容器詰飲料
US20060177559A1 (en) * 2005-02-04 2006-08-10 Pepsico, Inc. Stable beverage compositions containing tea polyphenols, flavonoids or catechins and methods
JP4690741B2 (ja) * 2005-02-22 2011-06-01 花王株式会社 非重合体カテキン類組成物の製造方法
JP2006246714A (ja) * 2005-03-08 2006-09-21 Suntory Ltd 呈味強化発酵茶葉および該茶葉を利用した濃厚呈味烏龍茶飲料
JP4630095B2 (ja) * 2005-03-15 2011-02-09 花王株式会社 茶抽出液の製造法
JP4694974B2 (ja) * 2005-05-20 2011-06-08 花王株式会社 精製緑茶抽出物の製造方法
JP4555184B2 (ja) * 2005-07-15 2010-09-29 ホシザキ電機株式会社 茶成分の抽出方法、同抽出方法を採用してなる茶飲料の製造方法、および、同製造方法を採用してなる給茶装置
KR20070026005A (ko) * 2005-09-01 2007-03-08 카오카부시키가이샤 정제 녹차 추출물의 제조 방법
JP4694921B2 (ja) * 2005-09-07 2011-06-08 花王株式会社 容器詰烏龍茶飲料
JP4694920B2 (ja) * 2005-09-07 2011-06-08 花王株式会社 容器詰紅茶飲料
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
DE602006016398D1 (de) * 2006-01-23 2010-10-07 Ito En Ltd Getränk
DE102006018844A1 (de) * 2006-04-22 2007-10-25 Lanxess Deutschland Gmbh Konservierungsmittel
PL1886585T3 (pl) * 2006-07-24 2009-04-30 Unilever Nv Ulepszony napój
US8518458B2 (en) * 2006-09-21 2013-08-27 Immune Guard, LLC Tea-derived compositions and methods of using same for cardiovascular health
DE102006045763A1 (de) * 2006-09-26 2008-04-03 Plantextrakt Gmbh & Co. Kg Grüntee-Extrakt, insbesondere zur Verwendung als funktionelles Lebensmittel, Nahrungsergänzungsmittel oder entsprechende Zutat, dessen Verwendung sowie Verfahren zur Herstellung eines solchen Grüntee-Extrakts
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
KR101118385B1 (ko) * 2006-12-14 2012-03-09 가부시키가이샤이토엔 차음료의 제조 방법
JP5297649B2 (ja) * 2006-12-27 2013-09-25 花王株式会社 容器詰飲料
WO2009002298A1 (en) * 2007-06-22 2008-12-31 Supranaturals, Llc Antioxidant drink for dietary supplementation
US20090110789A1 (en) * 2007-06-22 2009-04-30 Sakura Properties, Llc Antioxidant drink for dietary supplementation
EP2008702A1 (de) * 2007-06-25 2008-12-31 Unilever Plc Verfahren und Vorrichtung zur Membranfiltration
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
US20090022851A1 (en) * 2007-07-16 2009-01-22 Pepsico, Inc. Method of using oligomeric polyphenol compounds and bioflavonoids to alter bubble size of soft drinks
DE102007045958A1 (de) * 2007-09-26 2009-04-09 Lanxess Deutschland Gmbh Verfahren zur Dosierung von Dialkyldicarbonaten in Getränke
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
US8343552B2 (en) 2007-12-28 2013-01-01 Liveleaf, Inc. Therapeutic composition produced using punica granatum and hydrogen peroxide
JP5490020B2 (ja) * 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
KR20100112613A (ko) * 2008-02-07 2010-10-19 메이지 세이카 가부시키가이샤 테오브로민 고함유 조성물의 제조 방법 및 제조 장치
US20090252851A1 (en) * 2008-04-04 2009-10-08 Monjur Hossen Tea beverages and methods related thereto
JP5128350B2 (ja) * 2008-04-07 2013-01-23 森永製菓株式会社 カテキン類化合物の吸収促進用の医薬組成物
US8178147B2 (en) * 2008-06-26 2012-05-15 Pepsico, Inc. Coumalic acid to inhibit non-enzymatic browning in teas
JP5228229B2 (ja) * 2008-09-03 2013-07-03 高砂香料工業株式会社 低カフェイン茶類抽出物の製造方法
DE102008048714A1 (de) * 2008-09-24 2010-03-25 Lanxess Deutschland Gmbh Verfahren zur Konservierung von Getränken
CN102164500B (zh) * 2008-10-02 2014-08-20 荷兰联合利华有限公司 生产茶产品的方法
US20100086645A1 (en) * 2008-10-02 2010-04-08 Conopco, Inc., D/B/A Unilever Process for manufacturing tea products
PL2343987T3 (pl) * 2008-11-11 2013-05-31 Unilever Nv Herbaciana kompozycja
JP5676078B2 (ja) * 2008-12-26 2015-02-25 サントリー食品インターナショナル株式会社 風味増強剤及び香料組成物
US20110236550A1 (en) * 2009-02-18 2011-09-29 Daniel Perlman Stabilization of phenolic antioxidants in fat-containing foods
US8529977B2 (en) * 2009-02-27 2013-09-10 Ito En, Ltd. Green tea beverage packed in container
CA2753308A1 (en) * 2009-02-27 2010-09-02 Ito En, Ltd. Green tea beverage packed in container
CN102333450B (zh) * 2009-02-27 2014-07-09 株式会社伊藤园 容器装焙茶饮料
EP2298088A1 (de) * 2009-08-31 2011-03-23 LANXESS Deutschland GmbH Verfahren zur Konservierung von Lebensmitteln
KR20120093886A (ko) * 2009-09-18 2012-08-23 송경운 폴리페놀 유도체를 포함하는 기능성 미생물 발효 차 추출 엑기스 및 그것을 제조하는 방법
JP5739614B2 (ja) * 2009-11-09 2015-06-24 サントリー食品インターナショナル株式会社 アミノ酸を高濃度に含有する茶飲料
JP5118163B2 (ja) * 2010-01-29 2013-01-16 株式会社 伊藤園 容器詰緑茶飲料
JP5118164B2 (ja) * 2010-01-29 2013-01-16 株式会社 伊藤園 容器詰緑茶飲料
US20110236560A1 (en) * 2010-02-11 2011-09-29 Daniel Perlman Food supplementation with phenolic antioxidants in vinegar
US20110214318A1 (en) * 2010-03-05 2011-09-08 Sony Ericsson Mobile Communications Ab Paper Stock Card with Wireless Communication Capability
EP2549880B1 (de) 2010-03-25 2014-09-10 Unilever PLC Verfahren zur Herstellung von Teeprodukten
JP5612395B2 (ja) * 2010-08-12 2014-10-22 三井農林株式会社 容器詰め茶飲料のフロック発生抑制方法
US20130156929A1 (en) * 2010-08-31 2013-06-20 Ito En, Ltd. Green tea beverage packed in container and method of manufacturing the same
JP5800329B2 (ja) * 2010-10-14 2015-10-28 日研フード株式会社 インスタント茶及びその製造方法
EP2645879A1 (de) * 2010-11-30 2013-10-09 Unilever N.V. Veredelte pflanzenisolate und verfahren zur herstellung einer funktionellen lebensmittelzutat aus solch einem pflanzenisolat
AU2011344650B2 (en) * 2010-12-16 2014-05-01 Ekaterra Research and Development UK Limited Tea-based beverage
JP2012210180A (ja) * 2011-03-31 2012-11-01 Up Well:Kk 飲料の透明化方法
JP2012217356A (ja) * 2011-04-05 2012-11-12 Coca-Cola Co 容器詰飲料
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
CN102850235A (zh) * 2011-06-28 2013-01-02 西藏金稞集团有限责任公司 L-茶氨酸的一种纯化工艺
US20130084378A1 (en) * 2011-09-30 2013-04-04 Daesang Corporation Amino acid seasoning compositions comprising l-glutamic acid and l-lysine
CN104010517B (zh) * 2011-12-21 2018-06-22 花王株式会社 精制茶提取物的制造方法
KR102142539B1 (ko) * 2012-12-11 2020-08-07 롯데정밀화학 주식회사 복합체 형성용 조성물, 이로부터 형성된 복합체 및 이를 포함하는 경구 섭취용 조성물
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
JP6095980B2 (ja) * 2012-12-27 2017-03-15 花王株式会社 非重合体カテキン類の安定化剤
US20140205734A1 (en) * 2013-01-24 2014-07-24 Nathaniel Lawrence Method for creation and distribution of a tea flavored alcoholic beverage
CN104106696B (zh) * 2013-04-16 2019-02-12 农夫山泉股份有限公司 一种茶饮料及其制造方法
US9968109B2 (en) 2013-10-29 2018-05-15 Kao Corporation Green tea extract composition
JP5681262B1 (ja) * 2013-10-31 2015-03-04 キリンビバレッジ株式会社 茶飲料
WO2015094224A1 (en) * 2013-12-18 2015-06-25 Nestec S.A. Methods for increasing the clarity and refreshing attributes and reducing the bitterness and astringency of green tea
KR20150102326A (ko) 2014-02-28 2015-09-07 (주)아모레퍼시픽 카테킨 프리 차수 및 이를 포함하는 조성물
JP6487688B2 (ja) * 2014-12-10 2019-03-20 サントリーホールディングス株式会社 液状組成物の製造方法
JP6588224B2 (ja) * 2015-04-27 2019-10-09 サントリーホールディングス株式会社 炭酸感が改善された炭酸飲料
KR101899277B1 (ko) 2015-04-28 2018-09-14 카오카부시키가이샤 녹차 추출 조성물
EP3318134A1 (de) * 2016-11-04 2018-05-09 C.T.L. GmbH & Co.KG Verfahren zur herstellung eines flüssigen lebensmittels sowie flüssiges lebensmittel
JP6912190B2 (ja) * 2016-12-07 2021-08-04 キリンホールディングス株式会社 ステインフリー茶飲料
WO2019116351A2 (en) * 2017-12-14 2019-06-20 Hsrx Group, Llc Compositions and methods for treating and preventing a staphylococcal infection
JP7187171B2 (ja) * 2018-04-23 2022-12-12 アサヒ飲料株式会社 緑茶飲料、並びに、緑茶飲料のすっきり感及び緑茶感を調節する方法
JP6539377B2 (ja) * 2018-04-27 2019-07-03 花王株式会社 容器詰飲料
US11298357B2 (en) 2018-08-30 2022-04-12 Techmix, Llc Bovine supplement for neonatal calves
RU2707943C1 (ru) * 2018-12-05 2019-12-02 Гринми Са Напиток тонизирующий безалкогольный газированный
KR102345875B1 (ko) * 2019-09-16 2022-01-03 (주)알앤오식품 탈카페인 및 초고순도 에피갈로카테킨 갈레이트의 양산 방법
JP6963132B1 (ja) 2020-12-28 2021-11-05 サントリーホールディングス株式会社 エピガロカテキンガレートを含有する容器詰緑茶飲料
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074839A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074842A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
WO2024074843A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
WO2024095011A1 (en) 2022-11-04 2024-05-10 Nicoventures Trading Limited Oral product
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
GB202304445D0 (en) 2023-03-27 2023-05-10 Nicoventures Trading Ltd Oral product
GB202304518D0 (en) 2023-03-28 2023-05-10 Nicoventures Trading Ltd Oral product

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469553A (en) * 1943-06-14 1949-05-10 Drying & Concentrating Company Spray drier apparatus
US2852388A (en) * 1954-06-08 1958-09-16 Jose C Cortez Concentrated extracts of tea
US2771364A (en) * 1954-06-11 1956-11-20 American Home Prod Carbonation of coffee extract
CH453050A (fr) * 1965-12-09 1968-05-31 Nestle Sa Procédé de préparation d'un extrait de thé
US3531296A (en) * 1967-03-07 1970-09-29 Lipton Inc Thomas J Buffered instant tea extract
GB1207326A (en) * 1967-09-19 1970-09-30 Unilever Ltd Preparation of tea
IN142082B (de) * 1973-10-12 1977-05-28 R L Wickremasinghe
US4051264A (en) * 1975-09-05 1977-09-27 Thomas J. Lipton, Inc. Cold water extractable tea leaf and process
US4113886A (en) * 1977-09-28 1978-09-12 General Foods Corporation Membrane decaffeination
CH640704A5 (fr) * 1979-08-15 1984-01-31 Nestle Sa Procede de preparation d'un extrait concentre de cafe, the ou leurs succedanes.
EP0026399B1 (de) * 1979-09-19 1984-03-14 Aligena Ag Poröse, semipermeable, mit ionisierbaren Gruppen modifizierte Celluloseacetatmembranen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2949215C2 (de) * 1979-12-07 1988-12-01 Henkel KGaA, 4000 Düsseldorf Verfahren zum Konzentrieren wäßriger Lösungen temperaturempfindlicher Stoffe
US4301013A (en) * 1980-09-11 1981-11-17 Abcor, Inc. Spiral membrane module with controlled by-pass seal
US4435289A (en) * 1981-12-23 1984-03-06 Romicon, Inc. Series ultrafiltration with pressurized permeate
US4668525A (en) * 1982-01-05 1987-05-26 Thomas J. Lipton, Inc. Tea extraction process
US4560746A (en) * 1983-03-28 1985-12-24 The Hilton-Davis Chemical Co. Ultrafiltration process for purification of dyes useful in foodstuffs
US4483876A (en) * 1983-05-03 1984-11-20 Novo Industri A/S Enzymatic method for production of instant tea
US4552776A (en) * 1983-06-29 1985-11-12 The Procter & Gamble Company Process for preparation of tea color concentrate and product
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
US4900574A (en) * 1983-07-29 1990-02-13 Mars G.B. Limited Soluble or dissolved tea product
EP0162526A3 (de) * 1984-05-25 1988-01-07 The Procter & Gamble Company Flüssiges Teegemischkonzentrat
US4539216A (en) * 1984-05-25 1985-09-03 The Procter & Gamble Co. Process for preparing tea products
DE3515740A1 (de) * 1985-05-02 1986-11-06 Skw Trostberg Ag, 8223 Trostberg Verfahren zur entcoffeinierung von tee
DE3679714D1 (de) * 1985-05-08 1991-07-18 Nestle Sa Stabilisierung von tee in kaltem wasser.
JPS6236745A (ja) * 1985-08-09 1987-02-17 Olympus Optical Co Ltd 光学式ピツクアツプ
US4748033A (en) * 1986-05-07 1988-05-31 The Procter & Gamble Company Tea concentrate having freeze thaw stability and enhanced cold water solubility
JPS6336745A (ja) * 1986-07-31 1988-02-17 Potsuka Corp:Kk 茶抽出液の処理方法
US5198259A (en) * 1986-11-14 1993-03-30 Thomas J. Lipton, Inc. Concentrated tea extract
DE3640333C3 (de) * 1986-11-26 1994-08-11 Barth Raiser Hopfenextraktion Verfahren und Vorrichtung zur Herstellung von aromatisiertem, entcoffeiniertem Tee
US4874567A (en) * 1987-04-24 1989-10-17 Millipore Corporation Microporous membranes from polypropylene
US4797293A (en) * 1987-06-09 1989-01-10 General Foods Corporation Process for a non-clouding, concentrated tea extract
US4950332A (en) * 1988-03-17 1990-08-21 The Dow Chemical Company Process for decolorizing aqueous sugar solutions via adsorbent resins, and desorption of color bodies from the adsorbent resins
US4965083A (en) * 1988-03-23 1990-10-23 The Dow Chemical Company Removal of bitterness from citrus juices using a post-crosslinked adsorbent resin
US4906480A (en) * 1988-04-07 1990-03-06 Forsyth Dental Infirmary For Children Sweetness and flavor enhanced compositions and method of preparing such compositions
US4781830A (en) * 1988-04-19 1988-11-01 Osmonics, Inc. Cross flow filtration apparatus and closure assembly therefor
US4871397A (en) * 1988-05-09 1989-10-03 The Dow Chemical Company Process for decolorizing aqueous sugar solution
JPH01304101A (ja) * 1988-06-01 1989-12-07 Riide Chem Kk 複合多糖類の製造方法
US4874523A (en) * 1988-08-12 1989-10-17 Exxon Research And Engineering Company Method for reducing the cloud point of materials using an ultrafiltration separation process
US4963304A (en) * 1988-09-26 1990-10-16 The Dow Chemical Company Process for preparing microporous membranes
DE3838952A1 (de) * 1988-11-17 1990-05-23 Barth Raiser Hopfenextraktion Verfahren zur aromatisierung von behandeltem tee
DE69003291T2 (de) * 1989-04-06 1994-01-20 Unilever Nv Verfahren zur Herstellung eines Teeproduktes.
US4997564A (en) * 1989-04-06 1991-03-05 Filtron Technology Corporation Hollow fiber ultrafiltration replacement cartridge
US5258188A (en) * 1989-04-06 1993-11-02 Thomas J. Lipton Co., Division Of Conopco, Inc. Process of preparing a tea product
US4959149A (en) * 1989-06-15 1990-09-25 Koch Industries, Inc. Multiple tube series membrane filtration module and method of preparing same
US4946701A (en) * 1989-08-04 1990-08-07 Procter & Gamble Beverages
US4992177A (en) * 1989-10-11 1991-02-12 Koch Membrane Systems, Inc. Tubular filtration module and system with flow distributor and improved method of separation
US4935256A (en) * 1989-10-31 1990-06-19 Procter & Gamble Company Process for making green tea solids
US4988445A (en) * 1990-02-22 1991-01-29 Koch Membrane Systems, Inc. Spiral wound filtration system and method of utilizing same
JPH03280832A (ja) * 1990-03-29 1991-12-11 Nitto Denko Corp 茶飲料の製造方法
SU1706518A1 (ru) * 1990-04-10 1992-01-23 Тбилисский Региональный Отдел Всесоюзного Научно-Производственного Объединения По Чаю, Субтропическим Культурам И Чайной Промышленности Способ производства концентрата ча
US4994184A (en) * 1990-06-04 1991-02-19 Infinitex Ultrafiltration device and process
JPH0445744A (ja) * 1990-06-13 1992-02-14 Itouen:Kk 清澄緑茶飲料の製造方法
JP2911975B2 (ja) * 1990-08-01 1999-06-28 日東電工株式会社 コーヒー、茶類等の嗜好飲料の濃縮方法
US5192437A (en) * 1990-08-20 1993-03-09 Koch Membrane Systems, Inc. Spiral filtration module with improved cleanability and operating efficiency
US5069793A (en) * 1990-09-12 1991-12-03 Membrane Technology & Research, Inc. Membrane module
JPH04173094A (ja) * 1990-11-08 1992-06-19 Matsutani Kagaku Kogyo Kk 低カロリー・デキストリンの製造法
FR2676007B1 (fr) * 1991-04-30 1994-04-08 Tech Sep Membrane composite de nanofiltration.
JP2518752B2 (ja) 1991-08-21 1996-07-31 食品産業超高圧利用技術研究組合 茶飲料の殺菌方法
US5227062A (en) * 1991-11-25 1993-07-13 Osmonics, Inc. Adjustable flow control for fluid separation system comprising relatively moveable orifice plates
JPH05168407A (ja) 1991-12-24 1993-07-02 Toyo Seikan Kaisha Ltd 容器詰緑茶類飲料の製造方法
JPH05236877A (ja) * 1992-02-28 1993-09-17 Yaizu Miile Kyogyo Kumiai 濃縮緑茶の製造方法
JPH07112404B2 (ja) 1992-05-08 1995-12-06 協同組合ティーライフクリエイティブ 緑茶の製茶方法
JP3256883B2 (ja) * 1992-10-06 2002-02-18 日研フード株式会社 低カフェインの茶葉カテキン類の製造方法
US5356808A (en) * 1993-04-02 1994-10-18 A.E. Staley Manufacturing Company Highly fermentable, high maltose, non-crystallizing starch conversion syrup
US5470468A (en) * 1993-10-12 1995-11-28 Koch Membrane Systems, Inc. Spiral filtration module having bypass prevention flange
ES2153834T3 (es) * 1993-11-18 2001-03-16 Nestle Sa Procedimiento para la preparacion de te negro instantaneo.
AU1525695A (en) * 1994-01-10 1995-08-01 Procter & Gamble Company, The Tea extract and process for preparing
US5431940A (en) * 1994-02-24 1995-07-11 The Procter & Gamble Company Preparation of noncarbonated beverage products with improved microbial stability
US5445836A (en) * 1994-05-12 1995-08-29 Kraft Foods, Inc. Enzymatic clarification of tea extracts
US5464619A (en) * 1994-06-03 1995-11-07 The Procter & Gamble Company Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability
US5427806A (en) * 1994-08-08 1995-06-27 The Procter & Gamble Company Process for making a stable green tea extract and product
CN1071546C (zh) * 1994-08-08 2001-09-26 普罗克特和甘保尔公司 含茶和果汁的颜色稳定的组合物
US6063428A (en) * 1996-02-26 2000-05-16 The Procter & Gamble Company Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058882A (zh) * 2013-02-04 2013-04-24 湖南省茶业集团股份有限公司 一种分离天然茶氨酸的方法
CN103058882B (zh) * 2013-02-04 2014-06-18 湖南省茶业集团股份有限公司 一种分离天然茶氨酸的方法

Also Published As

Publication number Publication date
WO1997030597A1 (en) 1997-08-28
JP2001197863A (ja) 2001-07-24
EP0884953A1 (de) 1998-12-23
CA2248295C (en) 2002-07-23
BR9707675A (pt) 1999-04-13
US5879733A (en) 1999-03-09
CA2248295A1 (en) 1997-08-28
JP3174065B2 (ja) 2001-06-11
DE69709065D1 (de) 2002-01-24
JP3507433B2 (ja) 2004-03-15
ATE210384T1 (de) 2001-12-15
DE69709065T2 (de) 2002-08-22
JPH11504224A (ja) 1999-04-20
AU1972997A (en) 1997-09-10
US6268009B1 (en) 2001-07-31
US6063428A (en) 2000-05-16
CN1079646C (zh) 2002-02-27
ES2165585T3 (es) 2002-03-16
CN1214613A (zh) 1999-04-21

Similar Documents

Publication Publication Date Title
EP0884953B1 (de) Extrakt aus grünem tee, das einer kationenaustauschbehandlung und nanofiltration zur verbesserung der klarheit und farbe unterworfen wird
US7981449B2 (en) Production process of purified green tea extract
EP2022346B1 (de) In behältnis abgepacktes getränk
EP1527693B1 (de) Verpackte, Tee-gegründete Getränke
US8697171B2 (en) Preparation process of purified green-tea extract
EP2382877B1 (de) Grüntee-Extrakt
EP2177108B1 (de) Verfahren zur herstellung eines tee-extrakts
US20090104337A1 (en) Process for producing purified green tea extract
US20080026113A1 (en) Packaged tea beverage
KR101088670B1 (ko) 용기들이 음료 및 그 제조법
US20060141119A1 (en) Purified product of green tea extract and packaged beverage of high-catechin content with the purified product mixed therein
JP2009225728A (ja) 非重合体カテキン類含有精製緑茶抽出物の製造方法
EP2510797B1 (de) Verfahren zur herstellung eines gereinigten teeextrakts
EP1576887B1 (de) Verpacktes teegetränk
JP5820110B2 (ja) 精製茶抽出物
JP3660637B2 (ja) 緑茶飲料の製造法
JP2004222592A (ja) 茶抽出液の製造法
JP3532914B2 (ja) 容器詰飲料
JP3638560B2 (ja) 半発酵茶飲料、発酵茶飲料の製造法
JP5427499B2 (ja) 精製茶抽出物の製造方法
JP2012183079A (ja) 非重合体カテキン類含有精製緑茶抽出物の製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980902

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE DE ES FR GB GR NL

17Q First examination report despatched

Effective date: 19990126

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RBV Designated contracting states (corrected)

Designated state(s): AT BE DE ES FR GB GR NL

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE DE ES FR GB GR NL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20011212

REF Corresponds to:

Ref document number: 210384

Country of ref document: AT

Date of ref document: 20011215

Kind code of ref document: T

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MOHLENKAMP, MARVIN JOSEPH JR.

Inventor name: BUNGER, JOHN ROBERT

Inventor name: EKANAYAKE, ATHULA

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REF Corresponds to:

Ref document number: 69709065

Country of ref document: DE

Date of ref document: 20020124

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2165585

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20010402155

Country of ref document: GR

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20130218

Year of fee payment: 17

Ref country code: GB

Payment date: 20130125

Year of fee payment: 17

Ref country code: ES

Payment date: 20130221

Year of fee payment: 17

Ref country code: DE

Payment date: 20130228

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20130212

Year of fee payment: 17

Ref country code: GR

Payment date: 20130129

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20130128

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20130305

Year of fee payment: 17

BERE Be: lapsed

Owner name: THE *PROCTER & GAMBLE CY

Effective date: 20140228

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69709065

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20140901

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 210384

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140221

REG Reference to a national code

Ref country code: GR

Ref legal event code: ML

Ref document number: 20010402155

Country of ref document: GR

Effective date: 20140903

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20140221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140903

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140901

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20141031

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69709065

Country of ref document: DE

Effective date: 20140902

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140228

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140228

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140902

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140221

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20150327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140222